核医学・放射性医薬品の世界及び中国市場

• 英文タイトル：Global and China Nuclear Medicine & Radiopharmaceuticals Market Insights, Forecast to 2027

• レポートコード：QY2108PAL8899 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の当調査資料ではグローバルにおける核医学・放射性医薬品の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、核医学・放射性医薬品の種類別市場規模（診断、治療）、用途別市場規模（腫瘍、甲状腺、心臓病、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の核医学・放射性医薬品市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における核医学・放射性医薬品の種類別市場規模（2016年-2027年）：診断、治療 ・世界における核医学・放射性医薬品の用途別市場規模（2016年-2027年）：腫瘍、甲状腺、心臓病、その他 ・核医学・放射性医薬品の中国市場分析 - 核医学・放射性医薬品の中国市場規模（2016年-2027年） - 中国における核医学・放射性医薬品の主要プレイヤー別市場シェア - 中国における核医学・放射性医薬品の種類別市場規模：診断、治療 - 中国における核医学・放射性医薬品の用途別市場規模：腫瘍、甲状腺、心臓病、その他 ・核医学・放射性医薬品の北米市場（2016年-2027年） ・核医学・放射性医薬品のヨーロッパ市場（2016年-2027年） ・核医学・放射性医薬品のアジア太平洋市場（2016年-2027年） ・核医学・放射性医薬品の中南米市場（2016年-2027年） ・核医学・放射性医薬品の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：China Isotope & Radiation、Dongcheng、Jaco、Ciaeriar、Advanced Molecular-imaging Solution、Shanghai Atom Kexing ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・...

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.

Market Analysis and Insights: Global and China Nuclear Medicine & Radiopharmaceuticals Market
This report focuses on global and China Nuclear Medicine & Radiopharmaceuticals market.
In 2020, the global Nuclear Medicine & Radiopharmaceuticals market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Nuclear Medicine & Radiopharmaceuticals market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Nuclear Medicine & Radiopharmaceuticals Scope and Market Size
Nuclear Medicine & Radiopharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine & Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Nuclear Medicine & Radiopharmaceuticals market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Diagnostic
Therapeutic

Segment by Application
Oncology
Thyroid
Cardiology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing

レポート目次

---

1 Study Coverage
1.1 Nuclear Medicine & Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Market by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2016-2027
2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2016-2027
2.2 Global Nuclear Medicine & Radiopharmaceuticals, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nuclear Medicine & Radiopharmaceuticals Historical Market Size by Region (2016-2021)
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2022-2027)
2.4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2022-2027)

3 Global Nuclear Medicine & Radiopharmaceuticals Competitor Landscape by Players
3.1 Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Sales
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer (2016-2021)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Key Nuclear Medicine & Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2016-2021)
3.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nuclear Medicine & Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nuclear Medicine & Radiopharmaceuticals Revenue in 2020
3.2.6 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturers
3.4 Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type (2016-2021)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2021)
4.1.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Type (2022-2027)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application (2016-2021)
5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021)
5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2021)
5.1.3 Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2021)
5.2 Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Application (2022-2027)
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
6.1.1 China Nuclear Medicine & Radiopharmaceuticals Sales YoY Growth 2016-2027
6.1.2 China Nuclear Medicine & Radiopharmaceuticals Revenue YoY Growth 2016-2027
6.1.3 China Nuclear Medicine & Radiopharmaceuticals Market Share in Global Market 2016-2027
6.2 China Nuclear Medicine & Radiopharmaceuticals Market Size by Players (International and Local Players)
6.2.1 China Top Nuclear Medicine & Radiopharmaceuticals Players by Sales (2016-2021)
6.2.2 China Top Nuclear Medicine & Radiopharmaceuticals Players by Revenue (2016-2021)
6.3 China Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Type (2016-2021)
6.3.1 China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
6.3.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
6.3.3 China Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2021)
6.4 China Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2022-2027)
6.4.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
6.4.3 China Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type (2022-2027)
6.5 China Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Application (2016-2021)
6.5.1 China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
6.5.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
6.5.3 China Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2021)
6.6 China Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2022-2027)
6.6.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
6.6.3 China Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2022-2027)

7 North America
7.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
7.2 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021)
7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021)
8.2.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
9.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021)
9.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
10.2 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021)
10.2.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 China Isotope & Radiation
12.1.1 China Isotope & Radiation Corporation Information
12.1.2 China Isotope & Radiation Description and Business Overview
12.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
12.1.5 China Isotope & Radiation Recent Development
12.2 Dongcheng
12.2.1 Dongcheng Corporation Information
12.2.2 Dongcheng Description and Business Overview
12.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Products Offered
12.2.5 Dongcheng Recent Development
12.3 Jaco
12.3.1 Jaco Corporation Information
12.3.2 Jaco Description and Business Overview
12.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Products Offered
12.3.5 Jaco Recent Development
12.4 Ciaeriar
12.4.1 Ciaeriar Corporation Information
12.4.2 Ciaeriar Description and Business Overview
12.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Products Offered
12.4.5 Ciaeriar Recent Development
12.5 Advanced Molecular-imaging Solution
12.5.1 Advanced Molecular-imaging Solution Corporation Information
12.5.2 Advanced Molecular-imaging Solution Description and Business Overview
12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Products Offered
12.5.5 Advanced Molecular-imaging Solution Recent Development
12.6 Shanghai Atom Kexing
12.6.1 Shanghai Atom Kexing Corporation Information
12.6.2 Shanghai Atom Kexing Description and Business Overview
12.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Products Offered
12.6.5 Shanghai Atom Kexing Recent Development
12.11 China Isotope & Radiation
12.11.1 China Isotope & Radiation Corporation Information
12.11.2 China Isotope & Radiation Description and Business Overview
12.11.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.11.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
12.11.5 China Isotope & Radiation Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
13.2 Nuclear Medicine & Radiopharmaceuticals Market Drivers
13.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges
13.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nuclear Medicine & Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Diagnostic
Table 3. Major Manufacturers of Therapeutic
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions (2016-2021) & (K Units)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Regions (2016-2021)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
Table 16. Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2020)
Table 20. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2016-2021) (US$/Unit)
Table 21. Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 23. Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) (K Units)
Table 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 29. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) (K Units)
Table 36. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 37. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2016-2021)
Table 39. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Key Companies (2016-2021)
Table 46. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Company (2016-2021)
Table 47. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 48. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Company (2016-2021)
Table 49. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 50. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 51. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Nuclear Medicine & Radiopharmaceuticals Price (US$/Unit) by Type (2016-2021)
Table 53. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2022-2027)
Table 54. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2022-2027)
Table 55. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2022-2027)
Table 57. China Nuclear Medicine & Radiopharmaceuticals Price (US$/Unit) by Type (2022-2027)
Table 58. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 59. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 60. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Nuclear Medicine & Radiopharmaceuticals Price (US$/Unit) by Application (2016-2021)
Table 62. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2022-2027)
Table 63. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2022-2027)
Table 64. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2022-2027)
Table 66. China Nuclear Medicine & Radiopharmaceuticals Price (US$/Unit) by Application (2022-2027)
Table 67. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 68. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 69. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 75. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 76. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 77. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 79. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 87. China Isotope & Radiation Corporation Information
Table 88. China Isotope & Radiation Description and Business Overview
Table 89. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product
Table 91. China Isotope & Radiation Recent Development
Table 92. Dongcheng Corporation Information
Table 93. Dongcheng Description and Business Overview
Table 94. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Dongcheng Product
Table 96. Dongcheng Recent Development
Table 97. Jaco Corporation Information
Table 98. Jaco Description and Business Overview
Table 99. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Jaco Product
Table 101. Jaco Recent Development
Table 102. Ciaeriar Corporation Information
Table 103. Ciaeriar Description and Business Overview
Table 104. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Ciaeriar Product
Table 106. Ciaeriar Recent Development
Table 107. Advanced Molecular-imaging Solution Corporation Information
Table 108. Advanced Molecular-imaging Solution Description and Business Overview
Table 109. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Advanced Molecular-imaging Solution Product
Table 111. Advanced Molecular-imaging Solution Recent Development
Table 112. Shanghai Atom Kexing Corporation Information
Table 113. Shanghai Atom Kexing Description and Business Overview
Table 114. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Shanghai Atom Kexing Product
Table 116. Shanghai Atom Kexing Recent Development
Table 117. Nuclear Medicine & Radiopharmaceuticals Market Trends
Table 118. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Table 119. Nuclear Medicine & Radiopharmaceuticals Market Challenges
Table 120. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Table 121. Nuclear Medicine & Radiopharmaceuticals Customers List
Table 122. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020 & 2027
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Others
Figure 10. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Sales 2016-2027 (K Units)
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 19. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2020
Figure 21. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 23. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 25. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type in 2020
Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
Figure 29. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2020
Figure 30. China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Nuclear Medicine & Radiopharmaceuticals Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in Nuclear Medicine & Radiopharmaceuticals in 2020
Figure 34. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2016-2021)
Figure 35. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2016-2021)
Figure 37. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 41. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 42. U.S. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 49. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 50. Germany Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 63. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 64. China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 75. China Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 83. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 85. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 86. Mexico Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 87. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Brazil Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 89. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Argentina Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 91. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2016-2021 (K Units)
Figure 93. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 95. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 96. Turkey Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 97. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 99. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. UAE Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 101. UAE Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Nuclear Medicine & Radiopharmaceuticals Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed

---